Sunshine Guojian Pharmaceutical's (SHA:688336) attributable profit rose 50% year over year to 103.5 million yuan in the third quarter, according to a Wednesday filing with the Shanghai Stock Exchange.
EPS at the drug company increased 55% year over year to 0.17 yuan.
Operating income grew 36% year over year to 342.8 million yuan.
Shares slid 3% during Wednesday's trading.
Price (RMB): ¥22.77, Change: ¥-0.78, Percent Change: -3.31%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。